Team:Tec-Monterrey/projectresults
From 2011.igem.org
(Difference between revisions)
(2 intermediate revisions not shown) | |||
Line 518: | Line 518: | ||
- | + | <p><a href="https://2011.igem.org/Team:Tec-Monterrey/projectoverview">overview</a></p> | |
<p><a href="https://2011.igem.org/Team:Tec-Monterrey/projectparts">parts</a></p> | <p><a href="https://2011.igem.org/Team:Tec-Monterrey/projectparts">parts</a></p> | ||
<p><a href="https://2011.igem.org/Team:Tec-Monterrey/projectmodeling">genetic frame</a></p> | <p><a href="https://2011.igem.org/Team:Tec-Monterrey/projectmodeling">genetic frame</a></p> | ||
- | <p><a href="https://2011.igem.org/Team:Tec-Monterrey/projectresults">methods | + | <p><a href="https://2011.igem.org/Team:Tec-Monterrey/projectresults/methods">methods</a></p> |
+ | <p><a href="https://2011.igem.org/Team:Tec-Monterrey/projectresults">results</a></p> | ||
<p><a href="https://2011.igem.org/Team:Tec-Monterrey/teamha">human approach</a></p> | <p><a href="https://2011.igem.org/Team:Tec-Monterrey/teamha">human approach</a></p> | ||
<p><a href="https://2011.igem.org/Team:Tec-Monterrey/projectprotocols">protocols</a><p> | <p><a href="https://2011.igem.org/Team:Tec-Monterrey/projectprotocols">protocols</a><p> | ||
Line 612: | Line 613: | ||
<p class="textojustif"> | <p class="textojustif"> | ||
- | All the insoluble fractions of the transformed strains have a significant amount of a protein that matches the predicted weight of our chimeric construct (100kDa), in comparison to their negative controls (insoluble fraction of wild type lysates)(Figure 1). There is also no significant visual difference between each induced strain; this suggests that any strain is a good host for our construct, letting reduce the number of strains in future research. According to Clontech’s buffer kit user manual, our protein could be trapped in the pellet (insoluble phase) because of its high molecular weight (100kD > 40kD) and because it is a membrane- bound protein that can form multiprotein complexes and as we did not use Clontech’s TALON CellThru for direct purification from crude cell lysates (unclarified cell lysates), which is the solution proposed by the user manual in order to further solubilize proteins. Unclarified cell lysates were not further processed. | + | All the insoluble fractions of the transformed strains have a significant amount of a protein that matches the predicted weight of our chimeric construct (100kDa), in comparison to their negative controls (insoluble fraction of wild type lysates)(Figure 1). There is also no significant visual difference between each induced strain; this suggests that any strain is a good host for our construct, letting reduce the number of strains in future research. According to Clontech’s buffer kit user manual, our protein could be trapped in the pellet (insoluble phase) because of its high molecular weight (100kD > 40kD) and because it is a membrane- bound protein that can form multiprotein complexes and as we did not use Clontech’s TALON CellThru for direct purification from crude cell lysates (unclarified cell lysates), which is the solution proposed by the user manual in order to further solubilize proteins. Unclarified cell lysates were not further processed. |
</p><br><br> | </p><br><br> | ||
Line 627: | Line 628: | ||
<br><br> | <br><br> | ||
- | + | <p class="textojustif"> Future research should include identification of protein membrane display by periplasm extraction, Blue native electrophoresis for isolation of membrane protein complexes in enzymatically active form and SEM (Scanning Electron Microscope). | |
+ | <br> | ||
+ | <br> | ||
<br> | <br> | ||
- | |||
<center> | <center> | ||
Line 654: | Line 656: | ||
<p class="textojustif"> | <p class="textojustif"> | ||
- | In the cell-lysate cellulase activity assay (Figure 3) The glucose concentration in the soluble fraction of celD-estA was of 358 µM and in the Negative Control (C-) was of 323 µM.In the insoluble fraction, the glucose | + | In the cell-lysate cellulase activity assay (Figure 3) The glucose concentration in the soluble fraction of celD-estA was of 358 µM and in the Negative Control (C-) was of 323 µM.In the insoluble fraction, the glucose concentration of the celD-estA was 374 µM and in the Negative Control (C-) it was 264 µM. The difference in soluble and insoluble fractions with its negative control was 35 µM while the difference in the insoluble fraction was 110 µM. The result of the t-test was the rejection of the null hyphothesis, suggesting that the difference between them is also significant. |
+ | <br> | ||
<br> | <br> | ||
- | |||
<center><img src="https://static.igem.org/mediawiki/2011/f/fb/Thelsolinsol.png" alt="photo3" name="photo3" width="400" id="photo3"/></center> | <center><img src="https://static.igem.org/mediawiki/2011/f/fb/Thelsolinsol.png" alt="photo3" name="photo3" width="400" id="photo3"/></center> | ||
<br> | <br> | ||
<p class="textojustif"> | <p class="textojustif"> | ||
- | <small>Figure 3.Cellulase Activity of Cell lysates.The IUPAC Filter Paper Assay was assessed | + | <small>Figure 3. Cellulase Activity of Cell lysates.The IUPAC Filter Paper Assay was assessed for the soluble and insoluble fraction of the celD+estA strain and the Negative Control (C-). The glucose concentration in the soluble fraction of celD-estA was 358 µM and in the Negative Control (C-) it was 323 µM.In the insoluble fraction, the glucose contentration of the celD-estA was 374 µM and in the Negative Control (C-) it was 264 µM.</small> |
Line 674: | Line 676: | ||
<br> | <br> | ||
- | <p class="textojustif"> The final genetic | + | <p class="textojustif"> The final genetic construction for ompA + sacC was accomplished without the translation terminator sequence (<a href="http://partsregistry.org/Part:BBa_K633015">BBa_K633015</a>). |
- | Approximately 3 kb of the | + | Approximately 3 kb of the linearized plasmid containing ompA + sacC was detected in all lanes and 1.25 kb of restriction fragment was visualized in the lane 6. (Figure 4) |
<br> | <br> | ||
Line 691: | Line 693: | ||
<br> | <br> | ||
- | + | <br> | |
<center> | <center> | ||
<b>2.2. OmpA+sacC Expression</b> | <b>2.2. OmpA+sacC Expression</b> | ||
Line 697: | Line 699: | ||
<br> | <br> | ||
- | <p class="textojustif"> A visible protein band of the expected molecular wight (62.8 kDa) of the fusion protein (ompA+sacC) could not be confirmed by SDS-PAGE (Figure 5). However, as Lee <i>et al.</i> (2004) have proven, the fusion protein could hardly be detected by Coomassie blue staining as its expression was below the detection level of the method used | + | <p class="textojustif"> A visible protein band of the expected molecular wight (62.8 kDa) of the fusion protein (ompA+sacC) could not be confirmed by SDS-PAGE (Figure 5). However, as Lee <i>et al.</i> (2004) have proven, the fusion protein could hardly be detected by Coomassie blue staining as its expression was below the detection level of the method used. Our result may be due to the same reason. |
<br> | <br> | ||
<br> | <br> | ||
Line 723: | Line 725: | ||
<p class="textojustif"> | <p class="textojustif"> | ||
- | Whole cells of the <i>E. coli</i> strain (BL21SI) +sacC+ompA produced a fructose concentration of 350.71±60.97 µM which is 149.36 µM higher than the negative control cells (Figure 6) | + | Whole cells of the <i>E. coli</i> strain (BL21SI) +sacC+ompA produced a fructose concentration of 350.71±60.97 µM which is 149.36 µM higher than the negative control cells (Figure 6). A T-test with 2 tails and alpha value of 0.05 was carried out, and the null hypothesis of "the population means are the same" was rejected, indicating that there is a difference between the fructose concentration in the control strain and those of the sample strains. And although further investigation is required, the evidence we have is a strong indicator that the enzyme is active in the outer membrane of <i>E. coli</i>. |
<br> | <br> | ||
<br> | <br> | ||
Line 737: | Line 739: | ||
<br> | <br> | ||
<p class="textojustif"> | <p class="textojustif"> | ||
- | Further research will be focused on SDS-PAGE with a more efficient staining/blotting technique, expression of sacC | + | Further research will be focused on SDS-PAGE with a more efficient staining/blotting technique, expression of sacC fused to estA protein fragments, and more sacC enzymatic assays. |
</p> | </p> | ||